Two of India's top drugmakers are grappling with product recalls after
regulators in the U.S. spotted signs of impurities in their drugs. Sun Pharmaceuticals is recalling about 155,000 bottles of an eye solution, while two of Cipla's top pharma partners have pulled products made at its Goa plant.
